Discover if your new anti-cancer drug will work! Our validated platform uses intact patients tumors, maintains their complexity and cellular component, and overcomes organoids. This allows to reliably assess at the pre-clinical stage the efficacy of drugs in patients.
Some insights
We are former collaborators from Unil who worked together and invented the core platform technology. They have more than 12 years of experience in systems oncology and drug development in the public and private sectors. We are looking for experts in marketing&sales to prospect new customers and grow
